View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOD/DODOASHA | RIN: 0720-AB85 | Publication ID: Spring 2021 |
Title: ●Expanding TRICARE Access to Care in Response to the COVID-19 Pandemic | |
Abstract:
This interim final rule with comment will temporarily amend the TRICARE regulation at 32 CFR part 199 by: adding freestanding End Stage Renal Disease facilities as a category of TRICARE-authorized institutional provider and modifying the reimbursement for such facilities; adding coronavirus 2019 (COVID-19) Immunizers who are not otherwise an eligible TRICARE-authorized provider as providers eligible for reimbursement for COVID-19 vaccines and vaccine administration; and adopting Medicare New COVID-19 Treatments Add-on Payments (NTCAPs). |
|
Agency: Department of Defense(DOD) | Priority: Other Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Undetermined | Unfunded Mandates: No |
CFR Citation: 32 CFR 199 | |
Legal Authority: 5 U.S.C. 301 10 U.S.C. ch. 55 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Jahanbakhsh Badshah Healthcare Program Specialist - Reimbursement Department of Defense Office of Assistant Secretary for Health Affairs 16401 E. Centretech Parkway, Aurora, CO 80011 Phone:303 676-3881 Email: jahanbakhsh.badshah.civ@health.mil |